The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for two new formulations of ViiV ...

Allied Market Research published a report, titled, “HIV Injection Market by Distribution Channel (Hospital Pharmacy, Drug Stores and Retail Pharmacies, and Others): Global Opportunity Analysis and ...

It’s been 50 years of PrideFest in Denver and the two-day celebratory event’s entertainment lineup was just announced — and it includes some of the drag world’s ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Nicole LaBrosse, Chief Financial Officer, is ...

May 7, 2024 Halozyme Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...

Data taken from [10,33–38]. Blake Max's spouse is employed as a regional medical scientist for ViiV Healthcare, which manufactures dolutegravir. The authors have no other relevant affiliations ...

Sobi gains approval for an indication extension from the European Commission for Aspaveli for adults with PNH who have ...

TerSera has obtained Health Canada approval for ZOLADEX LA 10.8mg to manage oestrogen receptor-positive (ER+) early breast ...

PrEP could work for women too, but there's a gap in HIV rates among this demographic, especially Black women. Outside of PrEP's proven effectiveness, the below facts suggest the need for better ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today reported its financial and operating results for the first quarter ended March 31, 2024, and provided an update on its ...